Literature DB >> 22284588

A framework for discussion on how to improve prevention, management, and control of hypertension in Canada.

Norm Campbell1, Eric R Young, Denis Drouin, Barbara Legowski, Michael A Adams, Judi Farrell, Janusz Kaczorowski, Richard Lewanczuk, Margaret Moy Lum-Kwong, Sheldon Tobe.   

Abstract

Increased blood pressure is a leading risk for premature death and disability. The causes of increased blood pressure are intuitive and well known. However, the fundamental basis and means for improving blood pressure control are highly integrated into our complex societal structure both inside and outside our health system and hence require a comprehensive discussion of the pathway forward. A group of Canadian experts was appointed by Hypertension Canada with funding from Public Health Agency of Canada and the Heart and Stroke Foundation of Canada, Canadian Institute for Health Research (HSFC-CIHR) Chair in Hypertension Prevention and Control to draft a discussion Framework for prevention and control of hypertension. The report includes an environmental scan of past and current activities, proposals for key indicators, and targets to be achieved by 2020, and what changes are likely to be required in Canada to achieve the proposed targets. The key targets are to reduce the prevalence of hypertension to 13% of adults and improve control to 78% of those with hypertension. Broad changes in government policy, research, and health services delivery are required for these changes to occur. The Hypertension Framework process is designed to have 3 phases. The first includes the experts' report which is summarized in this report. The second phase is to gather input and priorities for action from individuals and organizations for revision of the Framework. It is hoped the Framework will stimulate discussion and input for its full intended lifespan 2011-2020. The third phase is to work with individuals and organizations on the priorities set in phase 2.
Copyright © 2012 Canadian Cardiovascular Society. Published by Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22284588     DOI: 10.1016/j.cjca.2011.11.008

Source DB:  PubMed          Journal:  Can J Cardiol        ISSN: 0828-282X            Impact factor:   5.223


  15 in total

Review 1.  Surgical, interventional, and device innovations in the management of hypertension.

Authors:  Sibu P Saha; Khaled M Ziada; Thomas F Whayne
Journal:  Int J Angiol       Date:  2015-03

2.  Canada's new Healthy Eating Strategy: Implications for health care professionals and a call to action.

Authors:  Simon L Bacon; Norm R C Campbell; Kim D Raine; Ross T Tsuyuki; Nadia A Khan; Manuel Arango; Janusz Kaczorowski
Journal:  Can Fam Physician       Date:  2019-06       Impact factor: 3.275

3. 

Authors:  Simon L Bacon; Norm R C Campbell; Kim D Raine; Ross T Tsuyuki; Nadia A Khan; Manuel Arango; Janusz Kaczorowski
Journal:  Can Fam Physician       Date:  2019-06       Impact factor: 3.275

4.  World Health Day: focusing on hypertension in 2013.

Authors:  Mark Gelfer; Denis Drouin; Martin Dawes; Norm Campbell
Journal:  Can Fam Physician       Date:  2013-04       Impact factor: 3.275

5.  Hypertension: Silent and/or ignored / L'hypertension silencieuse ou ignorée.

Authors:  Ross T Tsuyuki; Norm Campbell
Journal:  Can Pharm J (Ott)       Date:  2013-03

Review 6.  Hypertension in Developing Countries: A Major Challenge for the Future.

Authors:  M Mohsen Ibrahim
Journal:  Curr Hypertens Rep       Date:  2018-05-01       Impact factor: 5.369

7.  A novel transdermal nanoethosomal gel of lercanidipine HCl for treatment of hypertension: optimization using Box-Benkhen design, in vitro and in vivo characterization.

Authors:  Heba F Salem; Shahira F El-Menshawe; Rasha A Khallaf; Yasmine K Rabea
Journal:  Drug Deliv Transl Res       Date:  2020-02       Impact factor: 4.617

8.  Volunteerism, and alignment, are needed for a major paradigm shift in approaches to hypertension control: 2016 World Hypertension League Excellence Award in Hypertension Prevention and Control and the Distinguished Service Award.

Authors:  Norm R C Campbell
Journal:  J Clin Hypertens (Greenwich)       Date:  2017-04-20       Impact factor: 3.738

9.  The World Hypertension League challenges hypertension and cardiovascular organizations to develop strategic plans for the prevention and control of hypertension.

Authors:  Norm R C Campbell; Dan T Lackland; Liu Lisheng; Xin-Hua Zhang; Peter M Nilsson; Kimbree A Redburn; Mark L Niebylski
Journal:  J Clin Hypertens (Greenwich)       Date:  2015-04-10       Impact factor: 3.738

10.  Hypertension prevalence, awareness, treatment and control in national surveys from England, the USA and Canada, and correlation with stroke and ischaemic heart disease mortality: a cross-sectional study.

Authors:  Michel Joffres; Emanuela Falaschetti; Cathleen Gillespie; Cynthia Robitaille; Fleetwood Loustalot; Neil Poulter; Finlay A McAlister; Helen Johansen; Oliver Baclic; Norm Campbell
Journal:  BMJ Open       Date:  2013-08-30       Impact factor: 2.692

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.